ENOV
Enovis Corp
NYSE · Health Care
$22.59
+0.80 (+3.67%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 2.18B | 1.91B | 1.06B | 959.49M | 1.06B |
| Net Income | -853,997,643 | -674,800,595 | 75.06M | 74.78M | 72.61M |
| EPS | — | — | — | — | — |
| Profit Margin | -39.2% | -37.2% | 7.1% | 7.8% | 6.9% |
| Rev Growth | +13.9% | +13.9% | -9.2% | -5.1% | -8.6% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 220.68M | 220.68M | 531.23M | 570.05M | 575.91M |
| Total Equity | 425.28M | 425.28M | 640.20M | 642.51M | 611.09M |
| D/E Ratio | 0.52 | 0.52 | 0.83 | 0.89 | 0.94 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -442,874,594 | -369,386,184 | 149.31M | 123.09M | 130.61M |
| Free Cash Flow | — | — | 77.13M | 63.08M | 92.88M |